Literature DB >> 19446732

Characterization of chemokine receptor CXCR2 interacting proteins using a proteomics approach to define the CXCR2 "chemosynapse".

Dayanidhi Raman1, Nicole F Neel, Jiqing Sai, Raymond L Mernaugh, Amy-Joan L Ham, Ann J Richmond.   

Abstract

Chemokine-receptor signaling is initiated upon ligand binding to the receptor and continues through the process of endocytic trafficking by the association of a variety of adaptor proteins with the chemokine receptor. In order to define the adaptor proteins that associate with CXCR2 before and after ligand activation, a protocol was developed using differentiated HL-60 cells transfected to express CXCR2 stimulated or not stimulated with ligand for one minute. CXCR2-associating proteins were isolated by immunoprecipitation with CXCR2 antibody and the eluted proteins were electrophoretically run into the separating gel directly without a stacking gel. The stained single band was subjected to in-gel trypsin digestion. The tryptic peptides were subjected to, LC/MS/MS proteomic analysis. Proteins identified in a minimum of three of four separate experiments with multiple peptides were then validated as CXCR2 adaptor proteins by coimmunoprecipitation, GST pull-down studies, and immunocytochemical CXCR2-colocalization experiments using dHL-60-CXCR2 cells. Subsequently, a functional analysis of the interaction between CXCR2 and CXCR2 interacting proteins was performed. This approach can be used to characterize chemokine receptor-associating proteins over time both before and after ligand stimulation, allowing definition of the dynamic spatial and temporal formation of a "chemosynapse."

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19446732      PMCID: PMC3140414          DOI: 10.1016/S0076-6879(09)05215-X

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  16 in total

1.  Dynamics of a chemoattractant receptor in living neutrophils during chemotaxis.

Authors:  G Servant; O D Weiner; E R Neptune; J W Sedat; H R Bourne
Journal:  Mol Biol Cell       Date:  1999-04       Impact factor: 4.138

2.  Production of trans-lentiviral vector with predictable safety.

Authors:  John C Kappes; Xiaoyun Wu; John K Wakefield
Journal:  Methods Mol Med       Date:  2003

3.  Effects of flow and diffusion on chemotaxis studies in a microfabricated gradient generator.

Authors:  Glenn M Walker; Jiqing Sai; Ann Richmond; Mark Stremler; Chang Y Chung; John P Wikswo
Journal:  Lab Chip       Date:  2005-04-27       Impact factor: 6.799

4.  Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia.

Authors:  R Gallagher; S Collins; J Trujillo; K McCredie; M Ahearn; S Tsai; R Metzgar; G Aulakh; R Ting; F Ruscetti; R Gallo
Journal:  Blood       Date:  1979-09       Impact factor: 22.113

5.  WHIM syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12.

Authors:  Karl Balabanian; Bernard Lagane; José Luis Pablos; Lysiane Laurent; Thierry Planchenault; Olivier Verola; Celeste Lebbe; Delphine Kerob; Alain Dupuy; Olivier Hermine; Jean-François Nicolas; Véronique Latger-Cannard; Danièle Bensoussan; Pierre Bordigoni; Françoise Baleux; Françoise Le Deist; Jean-Louis Virelizier; Fernando Arenzana-Seisdedos; Françoise Bachelerie
Journal:  Blood       Date:  2004-11-09       Impact factor: 22.113

6.  Deletion of the COOH-terminal domain of CXC chemokine receptor 4 leads to the down-regulation of cell-to-cell contact, enhanced motility and proliferation in breast carcinoma cells.

Authors:  Yukiko Ueda; Nicole F Neel; Evemie Schutyser; Dayanidhi Raman; Ann Richmond
Journal:  Cancer Res       Date:  2006-06-01       Impact factor: 12.701

7.  Neutrophil chemotaxis in linear and complex gradients of interleukin-8 formed in a microfabricated device.

Authors:  Noo Li Jeon; Harihara Baskaran; Stephan K W Dertinger; George M Whitesides; Livingston Van de Water; Mehmet Toner
Journal:  Nat Biotechnol       Date:  2002-07-01       Impact factor: 54.908

8.  Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease.

Authors:  Paolo A Hernandez; Robert J Gorlin; John N Lukens; Shoichiro Taniuchi; Joze Bohinjec; Fleur Francois; Mary E Klotman; George A Diaz
Journal:  Nat Genet       Date:  2003-05       Impact factor: 38.330

9.  VASP is a CXCR2-interacting protein that regulates CXCR2-mediated polarization and chemotaxis.

Authors:  Nicole F Neel; Melanie Barzik; Dayanidhi Raman; Tammy Sobolik-Delmaire; Jiqing Sai; Amy J Ham; Raymond L Mernaugh; Frank B Gertler; Ann Richmond
Journal:  J Cell Sci       Date:  2009-05-12       Impact factor: 5.285

10.  Altered leukocyte response to CXCL12 in patients with warts hypogammaglobulinemia, infections, myelokathexis (WHIM) syndrome.

Authors:  Anna Virginia Gulino; Daniele Moratto; Silvano Sozzani; Patrizia Cavadini; Karel Otero; Laura Tassone; Luisa Imberti; Silvia Pirovano; Lucia D Notarangelo; Roberta Soresina; Evelina Mazzolari; David L Nelson; Luigi D Notarangelo; Raffaele Badolato
Journal:  Blood       Date:  2004-03-16       Impact factor: 22.113

View more
  12 in total

1.  CXCL1 and CXCL2 Inhibit the Axon Outgrowth in a Time- and Cell-Type-Dependent Manner in Adult Rat Dorsal Root Ganglia Neurons.

Authors:  Antonia Teona Deftu; Ruxandra Ciorescu; Roxana-Olimpia Gheorghe; Dan Mihăilescu; Violeta Ristoiu
Journal:  Neurochem Res       Date:  2019-08-17       Impact factor: 3.996

Review 2.  Chemokine receptor CXCR2: physiology regulator and neuroinflammation controller?

Authors:  Mike Veenstra; Richard M Ransohoff
Journal:  J Neuroimmunol       Date:  2012-03-22       Impact factor: 3.478

3.  Adaptor protein2 (AP2) orchestrates CXCR2-mediated cell migration.

Authors:  Dayanidhi Raman; Jiqing Sai; Oriana Hawkins; Ann Richmond
Journal:  Traffic       Date:  2014-04       Impact factor: 6.215

Review 4.  Decoding the chemokine network that links leukocytes with decidual cells and the trophoblast during early implantation.

Authors:  Rosanna Ramhorst; Esteban Grasso; Daniel Paparini; Vanesa Hauk; Lucila Gallino; Guillermina Calo; Daiana Vota; Claudia Pérez Leirós
Journal:  Cell Adh Migr       Date:  2016-02-18       Impact factor: 3.405

Review 5.  Chemokines in health and disease.

Authors:  Dayanidhi Raman; Tammy Sobolik-Delmaire; Ann Richmond
Journal:  Exp Cell Res       Date:  2011-01-09       Impact factor: 3.905

6.  LIM and SH3 protein-1 modulates CXCR2-mediated cell migration.

Authors:  Dayanidhi Raman; Jiqing Sai; Nicole F Neel; Catherine S Chew; Ann Richmond
Journal:  PLoS One       Date:  2010-04-19       Impact factor: 3.240

Review 7.  Chemokine receptors in epithelial ovarian cancer.

Authors:  Goda G Muralidhar; Maria V Barbolina
Journal:  Int J Mol Sci       Date:  2013-12-31       Impact factor: 5.923

8.  LASP-1: a nuclear hub for the UHRF1-DNMT1-G9a-Snail1 complex.

Authors:  N Duvall-Noelle; A Karwandyar; A Richmond; D Raman
Journal:  Oncogene       Date:  2015-05-18       Impact factor: 9.867

Review 9.  International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors.

Authors:  Francoise Bachelerie; Adit Ben-Baruch; Amanda M Burkhardt; Christophe Combadiere; Joshua M Farber; Gerard J Graham; Richard Horuk; Alexander Hovard Sparre-Ulrich; Massimo Locati; Andrew D Luster; Alberto Mantovani; Kouji Matsushima; Philip M Murphy; Robert Nibbs; Hisayuki Nomiyama; Christine A Power; Amanda E I Proudfoot; Mette M Rosenkilde; Antal Rot; Silvano Sozzani; Marcus Thelen; Osamu Yoshie; Albert Zlotnik
Journal:  Pharmacol Rev       Date:  2013-11-11       Impact factor: 25.468

Review 10.  New Frontiers for the Cytoskeletal Protein LASP1.

Authors:  Elke Butt; Dayanidhi Raman
Journal:  Front Oncol       Date:  2018-09-21       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.